SLN124 is a synthetic double-stranded siRNA oligonucleotide directed against TMPRSS6 mRNA and covalently linked to a ligand containing 3 N-acetylgalactosamine residues.
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.